ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ABC Abcam Plc

1,226.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Abcam Plc LSE:ABC London Ordinary Share GB00B6774699 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,226.00 1,240.00 1,246.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

ABCAM Plc Director's Dealings (3915V)

27/10/2014 2:31pm

UK Regulatory


TIDMABC

RNS Number : 3915V

ABCAM Plc

27 October 2014

 
 For immediate release   27 October 2014 
 

ABCAM PLC

("Abcam" or "the Company")

Directors' dealing: Share Incentive Plan

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, has today been notified of the following transactions to the benefit of Executive Directors, arising from the annual invitation to all UK based employees to participate in the Abcam plc Share Incentive Plan:

 
 Name           Partnership         Matching          Free Shares 
                 Shares purchased    Shares granted    awarded on 
                 on 24 October       on 24 October     24 October 
                 2014 at 398p        2014 at 398p      2014 at 398p 
                 per 0.2 pence       per 0.2 pence     per 0.2 pence 
                 Ordinary Share      Ordinary          Ordinary Share 
                                     Share 
 Alan Hirzel                  452               452               904 
               ------------------  ----------------  ---------------- 
 Jim Warwick                  452               452               904 
               ------------------  ----------------  ---------------- 
 Jeff Iliffe                  452               452               904 
               ------------------  ----------------  ---------------- 
 

The risk of forfeiture attached to the Matching Shares will normally be removed on the third anniversary of the award subject to continued employment and the retention of the Partnership Shares in connection with which they were awarded. The risk of forfeiture attached to the Free Shares will normally be removed on the third anniversary of the award subject to continued employment.

No consideration was paid by the above grantees for the award of the Matching and Free Shares and no consideration is due on the release of these shares.

For further information please contact:

 
 Abcam                                     + 44 (0) 1223 696 000 
 Alan Hirzel / Jeff Iliffe 
 Numis Securities - Nominated Adviser 
  and Joint Broker                         + 44 (0) 20 7260 1000 
 Michael Meade - Nominated Adviser 
 James Black - Corporate Broking 
 Peel Hunt LLP - Joint Broker              + 44 (0) 20 7418 8900 
 Clare Terlouw / Jock Maxwell MacDonald 
  - Corporate Broking 
 Brunswick                                 + 44 (0) 20 7404 5959 
 Justine Mcllroy / Robin Wrench / Emma 
  Walsh 
 

Notes for editors:

About Abcam plc

Abcam plc is a leading provider of protein research tools and services, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.

Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company's catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work.

Headquartered in Cambridge, UK, Abcam has eight global subsidiary offices enabling local services, multi-language support sells to over 100 countries. The Company was founded in 1998, and now employs over 740 people. Abcam was admitted to AIM in 2005 (AIM: ABC).

To find out more, please visit www.abcam.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSPGGUWUUPCGCM

1 Year Abcam Chart

1 Year Abcam Chart

1 Month Abcam Chart

1 Month Abcam Chart

Your Recent History

Delayed Upgrade Clock